Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses... Show more
Primis Financial Corp. operates a diversified community banking platform anchored by its core community bank, which runs 24 full-service branches across Virginia and Maryland and represents roughly two-thirds of the company's total balance sheet. The core bank has carved out a differentiated position through its proprietary V1BE digital banking application for commercial depositors, which supports more than $200 million in client relationships and has helped drive checking account growth of over 23% year-over-year. With a cost of deposits at just 1.59% in Q1 2026 and zero reliance on brokered deposits, the core franchise exhibits an enviable funding profile that provides a durable competitive moat.
Beyond the traditional community bank, Primis has built an integrated network of specialty lending divisions — Primis Mortgage, Mortgage Warehouse, and Panacea Financial (focused on medical, dental, and veterinary professionals) — that collectively broaden the revenue base and provide growth avenues not typically available to banks of similar size. The mortgage warehouse segment, supported by a team recruited from the industry, operates with efficiency ratios in the mid-20s and delivers pre-tax pre-provision ROA above 2.5%, making it a highly capital-efficient business. Panacea Financial, which ranks as the number one "Bank for doctors" on Google, has grown to approximately $600 million in loan commitments, servicing over 7,500 professionals nationwide. The digital deposit platform, holding approximately $1 billion in deposits with a cost trending downward toward 3.75%, provides scalable, nationally sourced funding that insulates the core bank from aggressive deposit pricing pressure. Together, these divisions create a strategically diversified model that can generate growth across different economic cycles.
Several identifiable catalysts could shape Primis Financial's stock trajectory over the coming quarters. The company's next earnings release, anticipated around late October 2026, will give investors an updated read on whether the margin expansion story remains intact. In Q1 2026, net interest margin (NIM) reached 3.43%, and CFO Matthew Switzer indicated expectations for NIM to inch into the "high 3.4% to 3.5%" range as the year progresses, driven by the full benefit of the $27 million subordinated debt redemption completed in January and the loan repricing cycle.
The scaling of the mortgage warehouse business represents another meaningful catalyst. With approved lines of $1.37 billion across 139 customers and outstanding balances that briefly exceeded $500 million in late Q1 2026, the division's contribution to consolidated earnings is expected to become increasingly visible as average balances trend toward management's $500 million annual target. On the retail mortgage side, production guidance of approximately $1.8 billion in closed volume at profitability trending above 60 basis points suggests the division could contribute meaningfully to noninterest income throughout 2026.
From an analyst coverage standpoint, sentiment has turned more favorable. The consensus recommendation from four analysts stands at "Strong Buy," with price targets ranging from $17.50 to $19.00 and a median of $18.00, implying potential upside from recent trading levels. Raymond James initiated coverage with a Buy rating and a $19 price target in June 2026, while KBW (Keefe, Bruyette & Woods) maintained a Buy rating and $18 target in July 2026. The trend in analyst ratings has moved from one Strong Buy in January 2026 to three Strong Buys and one Buy by mid-2026, indicating growing conviction in the company's turnaround narrative.
Additional catalysts include the anticipated restructuring of the bank-owned life insurance (BOLI) portfolio, expected to add approximately $1.2 million in annual noninterest income beginning late in Q2 2026, and the ramp-up of SBA (Small Business Administration) gain-on-sale income, projected at $500,000 to $600,000 per quarter from the core bank. The share repurchase authorization for up to 750,000 shares through December 2026 also provides a potential floor for the stock, though the pace of actual buybacks will depend on capital priorities.
As a regional bank with significant exposure to commercial real estate (CRE) lending, mortgage origination, and small-to-medium business banking, Primis Financial is inherently sensitive to the interest rate environment and broader credit cycle dynamics. The Federal Reserve's rate trajectory remains the single most important macro variable. A lower-rate environment could stimulate mortgage refinancing activity and improve credit conditions for CRE borrowers, directly benefiting both the mortgage warehouse and retail mortgage divisions. However, lower short-term rates also compress the yield on floating-rate loans, including warehouse lines typically priced at one-month SOFR (Secured Overnight Financing Rate) plus a spread.
The CRE office market in the Washington, D.C. metropolitan statistical area (MSA) — where two of Primis's largest problem credits are concentrated — continues to face structural headwinds from hybrid work patterns. Management has indicated that both credits are showing positive leasing momentum and improving capitalization rates, but resolution timelines remain uncertain. Broader consumer health, wage growth, and employment trends will influence loan demand across the core bank and Panacea divisions, while housing market activity directly drives mortgage origination volumes.
On the regulatory front, Primis benefits from operating below the $10 billion asset threshold, which exempts it from certain compliance burdens under the Dodd-Frank Act, including the Durbin Amendment's interchange fee caps. However, continued balance sheet growth could eventually push the bank across that threshold, introducing incremental regulatory costs. KBRA's January 2026 ratings downgrade — which cited comparatively low regulatory capital ratios, including CET1 (Common Equity Tier 1) and TCE (Tangible Common Equity) — suggests that capital adequacy will remain a key focus for credit rating agencies and institutional investors evaluating the stock.
Investors seeking a data-driven edge in evaluating stocks like Primis Financial may find value in Tickeron's Trend Prediction Engine. This AI-powered forecasting tool is designed to help traders assess whether a stock, ETF, or other tradable instrument is likely to exhibit bullish, bearish, or sideways price movement over the coming week or month. By analyzing historical patterns and real-time market data, the Trend Prediction Engine supports users in spotting developing trends, evaluating possible breakouts or reversals, and navigating predictions across a wide range of securities. The platform offers searchable prediction categories, historical context for each forecast, and alert-oriented functionality that can help traders stay informed about changing market conditions. Exploring tools like the Trend Prediction Engine can complement traditional fundamental analysis when forming a comprehensive view of a stock's potential direction.
Looking toward the remainder of 2026 and beyond, Primis Financial's outlook hinges on its ability to sustain the operating leverage that has defined recent quarters. Management's target of a 1.0% ROA — and its longer-term aspiration of 1.25% or better — reflects confidence that revenue growth can continue outpacing expense growth, even as the benefits from cost-cutting initiatives eventually plateau. The company's aggressive deployment of artificial intelligence tools, including Microsoft Copilot, aims to extract hundreds of hours per week in efficiency gains without significant incremental investment, potentially extending the runway for margin improvement.
The mortgage warehouse and Panacea divisions represent the clearest structural growth vectors. Mortgage warehouse, with its efficiency ratios in the 20s and a business model that generates high-quality floating-rate assets, could become a more significant driver of consolidated profitability as it scales toward and potentially beyond $1 billion in outstandings. Panacea's niche focus on medical professionals — a demographic with above-average income stability — provides a differentiated credit profile that may prove resilient across economic cycles. However, management has explicitly stated that it does not want mortgage-related earnings to exceed 20% of the bottom line, signaling a deliberate strategy to maintain balance across business lines.
Longer-term risks include the possibility that the consumer loan portfolio runoff — now down to $82 million from $132 million a year ago — does not fully resolve remaining credit overhangs, and that the two large CRE office credits require additional provisioning before resolution. Capital allocation priorities, including the pace of share repurchases, dividend sustainability (the company has declared 58 consecutive quarterly dividends), and potential M&A (mergers and acquisitions) activity, will also influence how the market values the franchise. Consensus analyst estimates project earnings per share of $1.58 for fiscal 2026 and $1.89 for fiscal 2027, reflecting expectations of continued earnings momentum. Whether Primis can deliver on these projections — and ultimately close the valuation gap relative to peers — will likely define the stock's trajectory through the remainder of the decade.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a regional bank
Industry RegionalBanks
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JDVNX | 29.37 | 0.23 | +0.79% |
| JHancock Disciplined Value NAV | |||
| WGMVX | 4.80 | 0.02 | +0.42% |
| Wasatch Micro Cap Value Institutional | |||
| ALVIX | 11.87 | 0.04 | +0.34% |
| American Century Focused Lg Cap Val Inv | |||
| ATGAX | 47.05 | 0.03 | +0.06% |
| Cantor Fitzgerald Equity Opp A | |||
| MSTFX | 12.65 | -0.04 | -0.32% |
| Morningstar International Equity | |||
A.I.dvisor indicates that over the last year, FRST has been closely correlated with FISI. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRST jumps, then FISI could also see price increases.
| Ticker / NAME | Correlation To FRST | 1D Price Change % | ||
|---|---|---|---|---|
| FRST | 100% | +0.75% | ||
| FISI - FRST | 70% Closely correlated | +0.48% | ||
| HBNC - FRST | 70% Closely correlated | -0.63% | ||
| COFS - FRST | 69% Closely correlated | +0.59% | ||
| BY - FRST | 68% Closely correlated | +0.13% | ||
| FBIZ - FRST | 68% Closely correlated | +4.39% | ||
More | ||||
| Ticker / NAME | Correlation To FRST | 1D Price Change % |
|---|---|---|
| FRST | 100% | +0.75% |
| FRST (15 stocks) | 77% Closely correlated | +0.48% |
| Regional Banks (361 stocks) | 63% Loosely correlated | +0.21% |
| Banks (434 stocks) | 63% Loosely correlated | +0.07% |
FRST broke above its upper Bollinger Band on June 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In of the 40 cases the stock fell afterwards. This puts the odds of success at .
The 10-day RSI Indicator for FRST moved out of overbought territory on July 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FRST as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for FRST turned negative on July 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for FRST entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FRST advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.919) is normal, around the industry mean (1.349). P/E Ratio (7.417) is within average values for comparable stocks, (24.359). FRST's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.981). Dividend Yield (0.025) settles around the average of (0.030) among similar stocks. P/S Ratio (2.300) is also within normal values, averaging (3.861).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FRST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.